Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Otitis Media: full-pipeline trial registry
4 of 16 indexed Otitis Media trials are currently recruiting.
Corpus placement: #1,060 of 28,707 conditions by registered trial count.
16 US clinical trials · 4 currently recruiting · #1,060 of 28,707 conditions by registered trial count
Otitis Media: 16 US clinical trials tracked, 4 recruiting.
Otitis Media is the subject of 16 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Boston Children's Hospital, running 3 of these trials.
Enrollment posture brief
Registry condition otitis-media
OPEN 4 | RECR 25% | LATE 3 | EARLY 3 | RANK #1060 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
Otitis Media lists 4 open slots (25% of 16 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Otitis Media on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Otitis Media is recruiting below its size-band peers.
4 of 16 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Otitis Media research.
Boston Children's Hospital accounts for 3 of 16 trials (18.8%). 14 distinct sponsors appear on at least one study for this condition label.
-
Typical Otitis Media enrolment sits around 165 participants.
Median target enrolment is 165 among the 15 trials that report a genuine target (sentinel values excluded). 6 of those (40%) plan for fewer than 100 participants.
-
Otitis Media research is mostly interventional.
13 interventional and 3 observational studies make up this index (81.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
16 total, page 1 of 1
Coherent Optical Detection of Middle Ear Disease
Medical College of Wisconsin
NCT05353569
Evaluation of Outcomes Following In-office Tympanostomy Using the Tula® System: a Prospective, Multi-center Registry
Smith & Nephew
NCT05915078
Does Topical Otic Drop Use at Time of Tympanostomy Tube Surgery Improve Outcomes When no Middle Ear Effusion is Present
Boston Children's Hospital
NCT03655665
In-Office Clinical Study of the Solo+ TTD
AventaMed DAC
NCT05741333
Diagnostic Utility of Otosight Middle Ear Scope
Baylor College of Medicine
NCT05641285
Digital Otoscope Versus Education and Feedback for Otitis Media in Young Children
Boston Children's Hospital
NCT06731660
Improving Otitis Media Care With Clinical Decision Support
Children's Hospital of Philadelphia
NCT00581711
ParentLink: Better and Safer Emergency Care for Children
Boston Children's Hospital
NCT00457600
Middle Ear Disease Before Age 3, Treatment With Ear Tubes, and Literacy and Attentional Abilities at Ages 9 to 11
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NCT00365092
The Impact of Ear Pain Anticipatory Guidance Counseling on Otitis Related Visits in a Low Income Population
University of Colorado, Denver
NCT02616458
In-Office Study of the Hummingbird® in Children 6 Months-21 Years Old
Preceptis Medical
NCT03544138
A Pilot Study to Evaluate the Efficacy of Montelukast in the Treatment of Acute Otitis Media (AOM) in Children
Deborah Gentile
NCT00189462
Tympanostomy Tube Placement in Children in the Office (Inova Study)
Integra LifeSciences Corporation
NCT01496287
Study of FAECC Scale (Modified FLACC) to Evaluate Ear Pain in Children With Acute Otitis Media
Arbor Pharmaceuticals
NCT01588535
Effect of Simethicone on Eustachian Tube Dysfunction
University of Pittsburgh
NCT01312038
Nervous System Manipulation and Botanicals for the Treatment of Recurrent Ear Infections in Children
National Center for Complementary and Integrative Health (NCCIH)
NCT00010465
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 3 | 1 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Otitis Media records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Otitis Media trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Otitis Media page
16 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Otitis Media trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Boston Children's Hospital sponsors the most Otitis Media trials on record, review their full trial history before evaluating a specific study. See Boston Children's Hospital's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Otitis Media condition card totals 16 registered trials; most-linked intervention Placebo; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.